» Articles » PMID: 2805066

The Murine Interleukin-4 Receptor: Molecular Cloning and Characterization of Secreted and Membrane Bound Forms

Overview
Journal Cell
Publisher Cell Press
Specialty Cell Biology
Date 1989 Oct 20
PMID 2805066
Citations 135
Authors
Affiliations
Soon will be listed here.
Abstract

Receptors for interleukin-4 (IL-4) are expressed at low levels on a wide variety of primary cells and cultured cell lines. Fluorescence-activated sorting of CTLL-2 cells resulted in the isolation of a subclone, CTLL 19.4, which expressed 10(6) IL-4 receptors per cell. These cells were used for the purification of IL-4 receptor protein and to prepare a hybrid-subtracted cDNA probe for isolation of cDNA clones. Three classes of IL-4 receptor cDNA were identified. The first encoded a 140 kd membrane bound IL-4 receptor containing extracellular, transmembrane, and cytoplasmic domains. The second class lacked the cytoplasmic region, and the third encoded a secreted form of the receptor. All cDNA clones expressed in COS-7 cells had IL-4 binding properties comparable to the native IL-4 receptor. The soluble form of the IL-4 receptor blocked the ability of IL-4 to induce CTLL cell proliferation and may represent a regulatory molecule specific for IL-4-dependent immune responses.

Citing Articles

Saponins, Astragaloside VII and Newly Synthesized Derivatives, Induce Dendritic Cell Maturation and T Cell Activation.

Yakubogullari N, Cagir A, Bedir E, Sag D Vaccines (Basel). 2023; 11(3).

PMID: 36992079 PMC: 10059926. DOI: 10.3390/vaccines11030495.


Soluble Immune Checkpoints Are Dysregulated in COVID-19 and Heavy Alcohol Users With HIV Infection.

Li W, Syed F, Yu R, Yang J, Xia Y, Relich R Front Immunol. 2022; 13:833310.

PMID: 35281051 PMC: 8904355. DOI: 10.3389/fimmu.2022.833310.


STAT3 determines IL-4 signalling outcomes in naïve T cells.

Deimel L, Li Z, Roy S, Ranasinghe C Sci Rep. 2021; 11(1):10495.

PMID: 34006897 PMC: 8131749. DOI: 10.1038/s41598-021-89860-7.


Soluble IL-7Rα/sCD127 in Health, Disease, and Its Potential Role as a Therapeutic Agent.

Barros P, Berthoud T, Aloufi N, Angel J Immunotargets Ther. 2021; 10:47-62.

PMID: 33728276 PMC: 7954429. DOI: 10.2147/ITT.S264149.


Antibody responses against the vaccine antigens Ov-103 and Ov-RAL-2 are associated with protective immunity to Onchocerca volvulus infection in both mice and humans.

George P, Hess J, Jain S, Patton J, Zhan T, Tricoche N PLoS Negl Trop Dis. 2019; 13(9):e0007730.

PMID: 31525197 PMC: 6762197. DOI: 10.1371/journal.pntd.0007730.